騰訊(0700.HK)大漲超7%再創歷史新高 市值超7.1萬億港元
格隆匯1月25日丨入選了格隆匯2021年“下注中國”十大核心資產名單的騰訊盤中持續拉昇,一度漲7.67%報744港元,再創上市新高,市值超7.1萬億港元;該股月內累漲超30%。騰訊是快手IPO前的第一大股東,持股21.5%,為快手上市的最大受益者。港媒稱快手招股價區間為105-115港元/股,籌資額或超480億港元,估值將介乎556億至609億美元(約4337億至4750億港元)。另外,花旗看好未來10年微信前景及遊戲份額不斷擴大,將騰訊目標價上調至876港元;瑞銀認為騰訊手機遊戲趨勢強勁,廣吿及雲端業務也見發展機會,管理層也或考慮發展金融科技產品,相信以上因素可推動騰訊於末來兩年收入增長約25%及近30%的EBIT增長,上調騰訊目標價至830港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.